Therapeutic relevance of GLP-1 Incretins are gut-derived peptide hormones released after nutrient ingestion that enhance glucose-dependent insulin secretion from pancreatic cells
An ongoing open-label prospective study is evaluating the effect of liraglutide (1.8 mg once a day) alone, liraglutide 1.8 mg daily with CPAP, CPAP alone, or without treatment in people with obstructive sleep apnea, obesity, and type 2 diabetes
The database contains reports of unintended and harmful side effects linked to medications
Supports Digestion: Improves gut health and promotes regular bowel movements
doi: 10.1111/add.16626 [DOI] [PMC free article] [PubMed] [Google Scholar] 35.Hendershot CS, Wardell JD, Samokhvalov AV, Rehm J
The 14.9% mean weight loss result was achieved with both the medication and lifestyle modifications combined